HIV/AIDS News

  • Home
  • HIV/AIDS News
  • Nominations for New Scientific/Clinical Members for the HHS Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission in the U.S.

Nominations for New Scientific/Clinical Members for the HHS Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission in the U.S.

Date: December 14, 2018
Source: AIDSinfo
URL: https://aidsinfo.nih.gov/guidelines/html/3/perinatal/0/

The Department of Health and Human Services (HHS) Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission in the United States (the Perinatal Guidelines Panel) is accepting nominations for new scientific/clinical members with expertise with pregnant women living with HIV and perinatal transmission. The Panel is seeking candidates with expertise in obstetrics/gynecology, pharmacology, pediatrics, and infectious disease studies in pregnant women.

Panel members critically evaluate new information and prepare guidelines revisions. The candidates shall be recognized experts in their areas of interest with a record of publications and presentations. The successful candidates shall serve a 3-year term beginning January 2019, with potential for reappointment. Because these are guidelines focused on the management of pregnant women living with HIV and perinatal transmission within the United States, candidates should be from the United States.

The Perinatal Guidelines Panel is a Working Group of the Office of AIDS Research Advisory Council (OARAC) of the National Institutes of Health (NIH). The Panel is composed of approximately 30 members who are clinicians, researchers, academicians, and HHS representatives with expertise in the management of pregnant women living with HIV (with training in either obstetrics/gynecology or women’s health, or nursing with expertise in women’s health) and interventions for perinatal transmission (such as pediatric specialists in HIV infection), as well as community representatives with knowledge of HIV infection in pregnant women and interventions for perinatal transmission.

The Panel meets monthly via teleconferencing to review and critically evaluate emerging scientific data relating to antiretroviral therapy in pregnant women and interventions for perinatal transmission to update the Recommendations for the Use of Antiretroviral Drugs in Pregnant Women with HIV Infection and Interventions to Reduce Perinatal HIV Transmission in the United States, which is found at https://aidsinfo.nih.gov.

Panel members are not compensated for their time commitment.

The nomination should include a curriculum vitae and a letter of nomination or letter of interest with specific reference to how the nominee would contribute to the work of the Panel. Please submit nominations to Maria Nkwanzi, AIDSinfo Guidelines Coordinator, at maria.nkwanzi@icf.com. We are requesting that nominations be submitted by January 11, 2019.